Mostrando 1,081 - 1,100 Resultados de 2,196 Para Buscar '"ave"', tiempo de consulta: 0.23s Limitar resultados
  1. 1081
    por Mizuno, Fumihiro, Kohno, Naoki
    Publicado 2023
    “…In addition, there were significant differences in θ(ave) between plantigrade and unguligrade locomotion. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 1082
    “…Clinical performance was excellent for all methods (median distance from the focus MNE = 2.4 mm; sLORETA = 3.5 mm; cMEM = 3.5 mm; dSPM = 6.8 mm, Ave = 0 mm). Ave showed the lowest distance between the map maximum and epilepsy focus (Dmin lower than cMEM, MNE, and dSPM, p = .021, p = .008, p < .001, respectively). cMEM showed the best spatial features, with lowest SD outside the focus (SD lower than all other methods, p < .001 consistently) and high contrast between the generator and surrounding regions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 1083
    “…Both the feature quality and classification performance are quantitatively evaluated on the same data set as used in AVE. It shows that, unlike AVE, without using any data augmentation, the best model produced from our research improves specificity in disease detection without compromising sensitivity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 1084
    “…The swimming speed indices significantly interplayed with SL, SI, F (max), F ( ave ), and I ( ave ). Partial correlations were computed with BA control. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 1085
    “…Convergent validity analysis results: PB (AVE = 0.52, CR = 0.87), SRB (AVE = 0.50, CR = 0.87), CRB (AVE = 0.51, CR = 0.86), TRB (AVE = 0.56, CR = 0.88). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 1086
    “…Estimates were similar in analyses restricted to vaccine-eligible patients (n = 1,768, aVE 23%, 95% CI 1%–40%) and patients aged ≥65 years (n = 1,407, aVE 20%, 95% CI −5% to 40%), but not in patients aged ≥75 years (n = 905, aVE 5%, 95% CI −37% to 35%). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 1087
    “…The convergent validity analysis using the Average Variance Extracted (AVE) and the Composite Reliability (CR) was adequate for all dimensions (personal: AVE = 0.626, CR = 0.893; study-related: AVE = 0.601, CR = 0.899; colleague-related: AVE = 0.677, CR = 0.913; teacher-related: AVE = 0.606, CR = 0.900). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 1088
    “…Ve1 encodes an extracellular leucine-rich repeat (eLRR) receptor-like protein (RLP) that serves as a cell surface receptor for recognition of the recently identified secreted Verticillium effector Ave1. To investigate recognition of Ave1 by Ve1, alanine scanning was performed on the solvent exposed β-strand/β-turn residues across the eLRR domain of Ve1. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 1089
    “…We conclude that β-Pix controls the spatial localization of Rac1 activity to drive collective AVE migration at a critical stage in mouse development.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 1090
  11. 1091
    “…The iLBBB patients had increased EL-AVE and EL-SUM during the late-diastole, isovolumic-systole, and rapid-ejection periods [EL-AVE in T2: 28.3 (8.7, 49.0) vs. 6.8 (5.4, 9.4) J/(s·m(3)); P=0.029]; [EL-AVE in T3: 24.7 (13.0, 46.8) vs. 7.2 (5.4, 10.8) J/(s·m(3)), P<0.001]; [EL-AVE in T4: 18.3 (12.0, 27.6) vs. 7.7 (4.1, 11.6) J/(s·m(3)), P=0.002]; [EL-SUM in T2: 8.3 (2.2, 14.5) vs. 2.1 (1.6, 3.2) J/(s·m), P=0.049]; [EL-SUM in T3: 7.6 (4.0, 14.5) vs. 2.2 (1.7, 3.3) J/(s·m), P<0.001]; [EL-SUM in T4: 5.3 (3.6, 9.7) vs. 2.2 (1.4, 3.0) J/(s·m), P=0.004]. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 1092
    “…The a* values were also associated with AveObs, but not linearly; AveObs between 2 (Blue) and 3 (Green) had lowest a*, and it increased as AveObs was more Light (<2) or more Olive (>3). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 1093
    “…RESULTS: The respective replacement of AveA1 and AveA3 (or module 7 in AveA3) of the avermectin polyketide synthase (PKS) in the avermectin high-producing strain S. avermitilis SA-01 with MilA1 and MilA3 (or module 7 in MilA3) of the milbemycin PKS resulted in the production of milbemycins A3, A4, and D in small amounts and their respective C5-O-methylated congener milbemycins B2, B3, and G as major products with total titers of approximately 292 mg/l. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 1094
    por Jiang, Yuhao, Tian, Yin, Wang, Zhongyan
    Publicado 2019
    “…In short, PerN, AffN and AveN associated with the amygdalar subregions separately presented different causality connectivity changes with ageing. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 1095
    por Guerrero, Francisco, 1528?-1599
    Publicado 1992
    Tabla de Contenidos: “…Ave Maria (a 4) (3:39) -- Alma Redemptoris mater (a 4) (3:23) -- Beata Dei genitrix, Maria (a 6) (5:13) -- Pater Noster (a 8) (4:51) -- O Domine Jesu Christe I (instrumental a 4) (3:28) -- O Domine Jesu Christe II (a 4) (3:25) -- O sacrum convivium (a 5) (3:21) -- Laudate Dominum de caelis (a 8) (3:12) -- Gabriel archangelus (a 4) (4:26) -- Ave, virgo sanctissima (a 5) (3:38) -- Salve Regina (a 4) (8:40) -- Regina caeli (a 8) (4:49) -- O altitudo divitiarum (instrumental a 8) (2:45) -- Trahe me post te, Virgo Maria (a 5) (4:17) -- Duo seraphim (a 12) (3:31) -- Ave Maria (a 8) (3:49)…”
    CD Audiom
  16. 1096
    Publicado 1995
    Tabla de Contenidos: “…Processional hymn: O gloriosa domina (2:00) -- Hymn: {thorn}e milde lomb isprad o rode (8:10) -- Conductus: Ave Maria gracia plena (2:07) -- Conductus: O Maria stella maris (3:23) -- Sequence: Stabat iuxta Christi crucem (5:29) -- Sequence: Stillat in stellam radium (3:53) --Sequence: Salve virgo singularis (3:17) -- Sequence: Stond wel, moder, under roode (8:51) -- Sequence: O Maria virgo pia (2:59) -- Hymn: In te concipitur (4:01) -- Sequence: Jesu Christes milde moder (8:20) --Motet: Veni mater gracie/Dou way, Robin (2:37) --Motet: O mors moreris/O vita vera/Mors (2:02) --Conductus: Salve virgo tonantis solium (1:21) --Sequence: Miserere miseris (1:12) -- Conductus: Ave Maria salus hominum (2:30) -- Conductus: Memor esto tuorum (2:00) -- Antiphon: Ave regina celorum (1:31).…”
    CD Audiom
  17. 1097
    “…However, like any new clinical technology, rigorous evaluation and proof of clinical effectiveness are required before AVE is implemented widely. In the current article, we outline essential clinical and technical considerations involved in building a validated DL‐based AVE tool for broad use as a clinical test.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 1098
  19. 1099
  20. 1100
    “…Simultaneously, the 20% enhancement of total canopy nitrogen concentration through the improvement of SLN(ave) (TNC-SLN(ave)) resulted in the highest AM(DAY) across cultivars, with an average increase of 11.2%. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS